Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: Results of a 30-center national surveillance study

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 12, 1996, Pages 2884-2886

  Doern, Gary V ^a,c   Brueggemann, Angela B ^a   Pierce, Gary ^a   Hogan, Tricia ^a   Preston Jr , Holley ^b   Rauch, Alan ^b  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b GLAXOSMITHKLINE   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAMASE; CEFACLOR; CEFIXIME; CEFPODOXIME; CEFPROZIL; CEFUROXIME; CHLORAMPHENICOL; CLARITHROMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; LORACARBEF; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; GRAM NEGATIVE INFECTION; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; NONHUMAN; ORAL DRUG ADMINISTRATION; OUTPATIENT; PRIORITY JOURNAL; UNITED STATES;

EID: 0029835919     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.12.2884     Document Type: Article

References (12)

1. Barry, A. L., M. A. Pfaller, P. C. Fuchs, and R. R. Packer. 1994. In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U. S. medical centers in 1992 and 1993. Antimicrob. Agents Chemother. 38:2414-2425.
2. Brown, B. A., R. J. Wallace, Jr., C. W. Flanagan, R. W. Wilson, J. I. Luman, and S. D. Redditt. 1989. Tetracycline and erythromycin resistance among clinical isolates of Branhamella catarrhalis Antimicrob. Agents Chemother. 33:1631-1633.
3. Doern, G. V. 1986. Branhamella catarrhalis - an emerging human pathogen. Diagn. Microbiol. Infect. Dis. 4:191-201.
4. Doern, G. V., and T. A. Tubert. 1988. In vitro activities of 39 antimicrobial agents for Branhamella catarrhalis and comparison of results with different quantitative susceptibility test methods. Antimicrob. Agents Chemother. 32: 259-261.
5. Farmer, T., and C. Reading. 1982. β-Lactamases of Branhamella catarrhalis and their inhibition by clavulanic acid. Antimicrob. Agents Chemother. 21: 506-508.
6. Jorgensen, J. H., G. V. Doern, L. A. Maher, A. W. Howell, and J. S. Redding. 1990. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrob. Agents Chemother. 34:2075-2080.
7. Marchant, C. D. 1990. Spectrum of disease due to Branhamella catarrhalis in children with particular reference to acute otitis media. Am. J. Med. 88(5A): 15S-19S.
8. Nash, D. R., R. J. Wallace, Jr., V. A. Steingrube, and P. A. Shurin. 1986. Isoelectric focusing of β-lactamases from sputum and middle ear isolates of Branhamella catarrhalis recovered in the United States. Drugs 31:48-54.
9. National Committee for Clinical Laboratory Standards. 1995. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. M7-A4. National Committee for Clinical Laboratory Standards, Villanova, Pa.
10. Sarubbi, F. A., J. W. Myers, J. J. Williams, and C. G. Shell. 1990. Respiratory infections caused by Branhamella catarrhalis. Am. J. Med. 88(5A):95-145.
11. Stobberingh, E. E., H. J. van Eck, A. W. Houben, and C. P. A. van Boven. 1986. Analysis of the relationship between ampicillin resistance and β-lactamase production in Branhamella catarrhalis. Drugs 31:23-27.
12. Wallace, R. J., Jr., D. R. Nash, and V. A. Steingrube. 1990. Antibiotic susceptibilities and drug resistance in Moraxella (Branhamella) catarrhalis. Am. J. Med. 88(5A):465-505.